home.social

#ezh2 — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #ezh2, aggregated by home.social.

  1. Un enzima chiamato EZH2 decide quali cellule tumorali diventeranno metastasi. Non modifica il DNA direttamente: lo avvolge, silenziando i geni che mantengono l'ordine nella divisione cellulare. Il 5% delle cellule del tumore triplo negativo usa questo meccanismo per viaggiare. La buona notizia? Esistono farmaci che bloccano EZH2 e sono già stati approvati.

    futuroprossimo.it/2025/10/ezh2

    #futuroprossimo #EZH2 #cancro #metastasi

  2. Seung Kim, Frederick Dick et al show that resting #Bcells are uniquely sensitive to #EZH2 #polycomb complex inhibition, which activates expression of repetitive genomic elements and subsequent #innateimmune receptor signaling in a form of viral mimicry

    embopress.org/doi/full/10.1525

  3. Seung Kim, Frederick Dick et al show that resting #Bcells are uniquely sensitive to #EZH2 #polycomb complex inhibition, which activates expression of repetitive genomic elements and subsequent #innateimmune receptor signaling in a form of viral mimicry

    embopress.org/doi/full/10.1525

  4. Seung Kim, Frederick Dick et al show that resting #Bcells are uniquely sensitive to #EZH2 #polycomb complex inhibition, which activates expression of repetitive genomic elements and subsequent #innateimmune receptor signaling in a form of viral mimicry

    embopress.org/doi/full/10.1525

  5. "These data identify developmental lineage as a key determinant of sensitivity to anti-GD2 based immunotherapies and credential #EZH2 inhibitors for clinical testing in combination with anti-GD2 antibody to enhance outcomes for children with #neuroblastoma".

    An article that I had missed, by Mabe et al., linking #mesenchymal #tumour cell state, #GD2 expression, #ST8SIA1 expression, and #immunotherapy #TherapyResistance.

    nature.com/articles/s43018-022

    Sadly, not open access.

  6. New discoveries about #Polycomb #EZH2 function in #MultipleMyeloma and a therapeutic avenue here:
    Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader. Oncogene (2023). doi.org/10.1038/s41388-023-026

  7. New discoveries about #Polycomb #EZH2 function in #MultipleMyeloma and a therapeutic avenue here:
    Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader. Oncogene (2023). doi.org/10.1038/s41388-023-026

  8. New discoveries about #Polycomb #EZH2 function in #MultipleMyeloma and a therapeutic avenue here:
    Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader. Oncogene (2023). doi.org/10.1038/s41388-023-026